This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
investment strategy
AstraZeneca CEO says AI is changing drug development and helping increase chances of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
The group led by JPMorgan Chase controls credit
The JPMorgan Chase & Co. building before the groundbreaking ceremony, at the company's new headquarters at 270 Park Avenue, in…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The liquidation of Cardinal Health was an overreaction. we would be buyers
We've taken a closer look at Cardinal Health's quarterly results and Thursday's post-settlement conference call. Our conclusion: The 4.9% drop…
Cramer Says Look For These 4 Stocks To Pair With Your High-Flying Tech Names
CNBC's Jim Cramer said Thursday that investors should look beyond the market's hottest trades and start looking for opportunities in…
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Pokémon Card Values Rise Amid Logan Paul Pikachu Auction
Pokémon cards are no longer just childhood collectibles. Popular trading cards from the 1990s and 2000s are increasingly being treated…
Eli Lilly Stock Falls After Analyst's Bearish Call: Here's Our Take
Eli Lilly shares fell 6% on Tuesday and are on track for their worst day since February after a downgrade…
We're dipping into our deep pockets of cash to buy more of this type of healthcare stock.
We are buying 90 shares of Cardinal Health at approximately $217. Following the transaction, Jim Cramer's Charitable Trust will own…